Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Net Income towards Common Stockholders (2021 - 2025)

Historic Net Income towards Common Stockholders for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to -$2.4 million.

  • HeartSciences' Net Income towards Common Stockholders fell 1190.44% to -$2.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$9.1 million, marking a year-over-year decrease of 1701.1%. This contributed to the annual value of -$8.9 million for FY2025, which is 3293.13% down from last year.
  • Per HeartSciences' latest filing, its Net Income towards Common Stockholders stood at -$2.4 million for Q4 2025, which was down 1190.44% from -$2.1 million recorded in Q3 2025.
  • HeartSciences' Net Income towards Common Stockholders' 5-year high stood at -$752051.0 during Q3 2021, with a 5-year trough of -$2.6 million in Q1 2025.
  • Over the past 5 years, HeartSciences' median Net Income towards Common Stockholders value was -$1.8 million (recorded in 2022), while the average stood at -$1.7 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first plummeted by 10925.5% in 2022, then surged by 2054.79% in 2023.
  • HeartSciences' Net Income towards Common Stockholders (Quarter) stood at -$1.0 million in 2021, then tumbled by 74.7% to -$1.8 million in 2022, then grew by 3.28% to -$1.7 million in 2023, then fell by 20.26% to -$2.1 million in 2024, then decreased by 11.9% to -$2.4 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$2.4 million for Q4 2025, versus -$2.1 million for Q3 2025 and -$2.1 million for Q2 2025.